2-ethyl-3-methyl-benzothiazolium | 46005-85-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻唑类
• 英文名称: 2-ethyl-3-methyl-benzothiazolium
• 英文别名: 2-Ethyl-3-methyl-1,3-benzothiazol-3-ium
• CAS: 46005-85-0
• 化学式: C₁₀H₁₂NS
• 分子量: 178.278
• InChiKey: TZTOZZCMUZYTBE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  32.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-ethyl-3-methyl-benzothiazolium 、 2-hydroxy-3-methoxy-5-(4-nitro-trans-phenylazo)-benzaldehyde 生成 3',8'-dimethoxy-3-methyl-6'-(4-nitro-phenylazo)-3H-spiro[benzothiazole-2,2'-chromene]
  参考文献：
  名称：

  Le Duc,J.C. et al., Comptes Rendus des Seances de l'Academie des Sciences, Serie C: Sciences Chimiques, 1976, vol. 282, p. 691 - 694

  摘要：

  DOI：

文献信息

• Kister, Jacky; Pommier, Henri Paul; Metzger, Jacques, Canadian Journal of Chemistry, 1984, vol. 62, p. 2372 - 2378
  作者：Kister, Jacky、Pommier, Henri Paul、Metzger, Jacques、Guglielmetti, Robert

  DOI：——

  日期：——
• Benzothiazolium compounds for use in methods of inhibiting NO production and TNF alpha and treating coronaviral infection
  申请人：National Health Research Institutes

  公开号：EP1627635B1

  公开（公告）日：2009-10-07
• BLOOD ANALYZER, BLOOD ANALYSIS METHOD, AND COMPUTER PROGRAM
  申请人：Sysmex Corporation

  公开号：EP2703813B1

  公开（公告）日：2017-05-03
• PHOTOCHROMIC COMPOUNDS
  申请人：Kumar Anil

  公开号：US20080051575A1

  公开（公告）日：2008-02-28

  Various non-limiting embodiments disclosed herein relate generally to photochromic compounds, which may be thermally reversible or non-thermally reversible, and articles made therefrom. Other non-limiting embodiments relate to photochromic-dichroic compounds, which may be thermally reversible or non-thermally reversible, and articles made therefrom. For example, one non-limiting embodiment provides a thermally reversible, photochromic compound adapted to have at least a first state and a second state, wherein the thermally reversible, photochromic compound has an average absorption ratio greater than 2.3 in at least one state as determined according to CELL METHOD. Another non-limiting embodiment provides a photochromic compound comprising: (a) at least one photochromic group chosen from a pyran, an oxazine, and a fulgide; and (b) at least one lengthening agent L attached to the at least one photochromic group and represented by the formula —[S 1 ] c -[Q 1 -[S 2 ] d ] d′ -[Q 2 -[S 3 ] e ] e′ -[Q 3 -[S 4 ] f ] f′ —S 5 —P, which is described herein.
• US4145537A
  申请人：——

  公开号：US4145537A

  公开（公告）日：1979-03-20